ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2021, 'Sodium-glucose co-transporter-2 inhibition and ocular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 23, pp. 252 - 257, http://dx.doi.org/10.1111/dom.14197
,2021, 'Ultra-low-dose quadruple combination blood pressure–lowering therapy in patients with hypertension: The QUARTET randomized controlled trial protocol', American Heart Journal, 231, pp. 56 - 67, http://dx.doi.org/10.1016/j.ahj.2020.09.017
,2021, 'Vital signs during the COVID-19 outbreak: A retrospective analysis of 19,960 participants in Wuhan and four nearby capital cities in China', Global Heart, 16, pp. 47, http://dx.doi.org/10.5334/GH.913
,2021, 'Availability, Formulation, Labeling, and Price of Low-sodium Salt Worldwide: Environmental Scan (Preprint)', JMIR Public Health and Surveillance, 7, http://dx.doi.org/10.2196/27423
,2021, 'Canagliflozin and Cardiovascular Outcomes in Patients With and Without Peripheral Artery Disease At Baseline: Data from the CANVAS Program and CREDENCE Trials', Heart Lung and Circulation, 30, pp. s215, http://dx.doi.org/10.1016/j.hlc.2021.06.263
,2021, 'Circulating Metabolites to Predict Renal Outcomes in CANVAS Type 2 Diabetes Mellitus Population', Journal of the American Society of Nephrology, 32, pp. 47 - 47, http://dx.doi.org/10.1681/asn.20213210s147a
,2021, 'Corrigendum', ESC Heart Failure, 8, pp. 3447 - 3447, http://dx.doi.org/10.1002/ehf2.13408
,2021, 'Estimating the potential impact of Australia’s reformulation programme on households’ sodium purchases', BMJ Nutrition, Prevention & Health, 4, pp. 49 - 58, http://dx.doi.org/10.1136/bmjnph-2020-000173
,2021, 'KidneyIntelX as an Enrichment Tool for Clinical Trials in Early Diabetic Kidney Disease', Journal of the American Society of Nephrology, 32, pp. 263 - 263, http://dx.doi.org/10.1681/asn.20213210s1263a
,2020, 'Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study', Journal of the American College of Cardiology, 76, pp. 2982 - 3021, http://dx.doi.org/10.1016/j.jacc.2020.11.010
,2020, 'Effects of canagliflozin in patients with baseline eGFR <30 ml/min per 1.73 m2: Subgroup analysis of the randomized CREDENCE trial', Clinical Journal of the American Society of Nephrology, 15, pp. 1705 - 1714, http://dx.doi.org/10.2215/CJN.10140620
,2020, 'Correction to: Contribution of major food companies and their products to household dietary sodium purchases in Australia (International Journal of Behavioral Nutrition and Physical Activity, (2020), 17, 1, (81), 10.1186/s12966-020-00982-z)', International Journal of Behavioral Nutrition and Physical Activity, 17, pp. 159, http://dx.doi.org/10.1186/s12966-020-01064-w
,2020, 'The impact of voluntary front-of-pack nutrition labelling on packaged food reformulation: A difference-in-differences analysis of the Australasian Health Star Rating scheme', PLoS Medicine, 17, pp. e1003427, http://dx.doi.org/10.1371/journal.pmed.1003427
,2020, 'Effects of Canagliflozin on Amino-Terminal Pro–B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction', Journal of the American College of Cardiology, 76, pp. 2076 - 2085, http://dx.doi.org/10.1016/j.jacc.2020.09.004
,2020, 'Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial', The Lancet Diabetes and Endocrinology, 8, pp. 903 - 914, http://dx.doi.org/10.1016/s2213-8587(20)30300-4
,2020, 'Effects of canagliflozin on initiation of insulin and other antihyperglycaemic agents in the CANVAS Program', Diabetes, Obesity and Metabolism, 22, pp. 2199 - 2203, http://dx.doi.org/10.1111/dom.14143
,2020, 'Seventeen-year associations between diet quality defined by the health star rating and mortality in australians: The australian diabetes, obesity and lifestyle study (ausdiab)', Current Developments in Nutrition, 4, pp. nzaa157 - nzaa157, http://dx.doi.org/10.1093/cdn/nzaa157
,2020, 'The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program', International Journal of Cardiology, 318, pp. 126 - 129, http://dx.doi.org/10.1016/j.ijcard.2020.06.011
,2020, 'Different eGFR decline thresholds and renal effects of canagliflozin: Data from the CANVAS program', Journal of the American Society of Nephrology, 31, pp. 2446 - 2456, http://dx.doi.org/10.1681/ASN.2019121312
,2020, 'Estimated 24-Hour Urinary Sodium Excretion and Incident Cardiovascular Disease and Mortality among 398628 Individuals in UK Biobank', Hypertension, 76, pp. 683 - 691, http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.14302
,2020, 'Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes', Kidney International, 98, pp. 769 - 777, http://dx.doi.org/10.1016/j.kint.2020.04.051
,2020, 'Prospective associations of four nutrient profiles with weigh gain, overweight and obesity risk', European Journal of Public Health, 30, pp. ckaa166.1285 - V1009, http://dx.doi.org/10.1093/eurpub/ckaa166.1285
,2020, 'Impact of salt substitute and stepwise reduction of salt supply on blood pressure in residents in senior residential facilities: Design and rationale of the DECIDE-Salt trial', American Heart Journal, 226, pp. 198 - 205, http://dx.doi.org/10.1016/j.ahj.2020.05.013
,2020, 'Rationale, design, and baseline characteristics of the Salt Substitute in India Study (SSiIS): The protocol for a double-blinded, randomized-controlled trial', Journal of Clinical Hypertension, 22, pp. 1504 - 1512, http://dx.doi.org/10.1111/jch.13947
,2020, 'The impact of 2019 novel coronavirus on heart injury: A Systematic review and Meta-analysis', Progress in Cardiovascular Diseases, 63, pp. 518 - 524, http://dx.doi.org/10.1016/j.pcad.2020.04.008
,2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833
,2020, 'Contribution of major food companies and their products to household dietary sodium purchases in Australia', International Journal of Behavioral Nutrition and Physical Activity, 17, pp. 81, http://dx.doi.org/10.1186/s12966-020-00982-z
,2020, '27-OR: Effect of Canagliflozin on Total Hospitalization for Heart Failure Events in Patients with Type 2 Diabetes and Chronic Kidney Disease', Diabetes, 69, http://dx.doi.org/10.2337/db20-27-or
,2020, 'Is salt substitution ready for prime time?', Nature Reviews Cardiology, 17, pp. 325 - 326, http://dx.doi.org/10.1038/s41569-020-0365-0
,2020, 'P1013CANAGLIFLOZIN AND RISK OF GENITAL INFECTIONS AND URINARY TRACT INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE- A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', Nephrology Dialysis Transplantation, 35, pp. gfaa142.p1013, http://dx.doi.org/10.1093/ndt/gfaa142.p1013
,2020, 'P1019CANAGLIFLOZIN AND RISK OF SKIN AND SOFT TISSUE INFECTIONS IN PEOPLE WITH DIABETES MELLITUS AND KIDNEY DISEASE - A POST-HOC ANALYSIS OF THE CREDENCE TRIAL', Nephrology Dialysis Transplantation, 35, http://dx.doi.org/10.1093/ndt/gfaa142.p1019
,2020, 'The effects of a supermarket-based intervention on the nutritional quality of private-label foods: A prospective study', Nutrients, 12, pp. 1 - 16, http://dx.doi.org/10.3390/nu12061692
,2020, 'Uptake of australia’s health star rating system 2014–2019', Nutrients, 12, pp. 1 - 13, http://dx.doi.org/10.3390/nu12061791
,2020, 'The effect of canagliflozin on amputation risk in the CANVAS program and the CREDENCE trial.', Diabetes Obes Metab, 22, pp. 1753 - 1766, http://dx.doi.org/10.1111/dom.14091
,2020, 'A Systematic Review of the Sources of Dietary Salt Around the World', Advances in Nutrition, 11, pp. 677 - 686, http://dx.doi.org/10.1093/advances/nmz134
,2020, 'Renal, cardiovascular, and safety outcomes of canagliflozin by baseline kidney function: A secondary analysis of the CREDENCE randomized trial', Journal of the American Society of Nephrology, 31, pp. 1128 - 1139, http://dx.doi.org/10.1681/ASN.2019111168
,2020, 'Reply: Mediators of the Effects of Canagliflozin on Heart Failure: Central Role of the Cardiorenal Axis', JACC: Heart Failure, 8, pp. 427, http://dx.doi.org/10.1016/j.jchf.2020.02.005
,2020, 'Salt-related knowledge, attitudes and behaviors (KABS) among victorian adults following 22-months of a consumer awareness campaign', Nutrients, 12, pp. 1216, http://dx.doi.org/10.3390/nu12051216
,2020, 'Sex disparities in cardiovascular outcome trials of populations with diabetes: A Systematic Review and Meta-analysis', Diabetes Care, 43, pp. 1157 - 1163, http://dx.doi.org/10.2337/dc19-2257
,2020, 'Estimated population wide benefits and risks in China of lowering sodium through potassium enriched salt substitution: Modelling study', The BMJ, 369, pp. m824, http://dx.doi.org/10.1136/bmj.m824
,2020, 'A Novel Cardioprotective Therapy That Also Improves Glycemia', JAMA - Journal of the American Medical Association, 323, pp. 1349 - 1350, http://dx.doi.org/10.1001/jama.2020.1905
,2020, 'A comparison of the nutritional qualities of supermarket’s own and regular brands of bread in sweden', Nutrients, 12, pp. 1162, http://dx.doi.org/10.3390/nu12041162
,2020, 'Changes in sodium levels of processed foods among the International Food and Beverage Association member companies in Australia: 2013–2017', Journal of Food Composition and Analysis, 87, pp. 103405, http://dx.doi.org/10.1016/j.jfca.2019.103405
,2020, 'Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program', Diabetes, Obesity and Metabolism, 22, pp. 530 - 539, http://dx.doi.org/10.1111/dom.13920
,2020, 'Interim effects of salt substitution on urinary electrolytes and blood pressure in the China Salt Substitute and Stroke Study (SSaSS)', American Heart Journal, 221, pp. 136 - 145, http://dx.doi.org/10.1016/j.ahj.2019.12.020
,2020, 'Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017', The Lancet, 395, pp. 709 - 733, http://dx.doi.org/10.1016/S0140-6736(20)30045-3
,2020, 'Effect of dose and duration of reduction in dietary sodium on blood pressure levels: Systematic review and meta-analysis of randomised trials', The BMJ, 368, pp. m315, http://dx.doi.org/10.1136/bmj.m315
,2020, 'A Community-Based Intervention for Managing Hypertension in Rural South Asia.', New England Journal of Medicine, 382, pp. 717 - 726, http://dx.doi.org/10.1056/nejmoa1911965
,2020, 'Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial', Circulation, 141, pp. 407 - 410, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.044359
,2020, 'Sodium-Glucose Cotransporter 2 Inhibition for the Prevention of Cardiovascular Events in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis', Journal of the American Heart Association, 9, pp. e014908, http://dx.doi.org/10.1161/JAHA.119.014908
,